Sunday, February 28, 2010
King Thrombin market yields lower results
THROMBIN-JMI® (thrombin, topical, bovine, USP) net sales totaled $44 million during the fourth quarter and $183 million for the year ended December 31, 2009, compared to $57 million during the fourth quarter and $255 million during the year ended December 31, 2008.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment